Clinical Trials Directory

Trials / Completed

CompletedNCT05462327

Low Fresh Gas Flow in Prone Position

Low Fresh Gas Flow and Normal Gas Flow Anesthesia in Patients Undergoing Surgery in Prone Position: Impact on Hemodynamics and Regional Cerebral Oxygenation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
46 (actual)
Sponsor
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Low flow anesthesia in the prone position was safe in terms of systemic hemodynamics and did not reduce cerebral oxygenation compared to normal flow.

Detailed description

Patients were randomly allocated to either low fresh gas flow(LF, 0,5 L/min during maintenance) or normal flow (NF, 2 L/min)) general anesthesia. In both groups, participants were first administered with 100% oxygen at a 4 L/min flow rate. Propofol 2-2,5 mg/kg, rocuronium bromide 0,6 mg/kg, and fentanyl 1 mcg/kg IV were used for anesthesia induction.In the operating room, pulse rate, mean arterial pressure (MAP), peripheral hemoglobin oxygen saturation (spO2), and right and left side regional cerebral oxygen saturation (Masimo's O3 regional oximetry device) were measured before premedication and anesthesia induction, at 10 minutes after endotracheal intubation, at 10 minutes after prone positioning, at 1st, 2nd, 3rd, 4th and 5th hours of operation, before repositioning to supine, after the resumption of supine position and at 5 minutes after extubation. In conclusion, low flow anesthesia in patients undergoing surgery in the prone position did not cause a reduction in cerebral oxygenation compared to normal flow.

Conditions

Interventions

TypeNameDescription
PROCEDURELow Fresh Gas Flow in Prone PositionIn the low fresh gas flow group, the flow rate was reduced to 0.5 L/min
PROCEDURENormal Fresh Gas Flow in Prone PositionIn the normal flow rate group, the gas flow rate was reduced to 2 L/min during the maintenance phase.

Timeline

Start date
2019-10-01
Primary completion
2020-03-31
Completion
2020-03-31
First posted
2022-07-18
Last updated
2022-07-18

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05462327. Inclusion in this directory is not an endorsement.